484 related articles for article (PubMed ID: 15090553)
1. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
Schaap FG; Rensen PC; Voshol PJ; Vrins C; van der Vliet HN; Chamuleau RA; Havekes LM; Groen AK; van Dijk KW
J Biol Chem; 2004 Jul; 279(27):27941-7. PubMed ID: 15090553
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.
Merkel M; Loeffler B; Kluger M; Fabig N; Geppert G; Pennacchio LA; Laatsch A; Heeren J
J Biol Chem; 2005 Jun; 280(22):21553-60. PubMed ID: 15774484
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants.
Grosskopf I; Baroukh N; Lee SJ; Kamari Y; Harats D; Rubin EM; Pennacchio LA; Cooper AD
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2573-9. PubMed ID: 16166565
[TBL] [Abstract][Full Text] [Related]
4. Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.
Shu X; Nelbach L; Weinstein MM; Burgess BL; Beckstead JA; Young SG; Ryan RO; Forte TM
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2504-9. PubMed ID: 20966404
[TBL] [Abstract][Full Text] [Related]
5. Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL.
Westerterp M; de Haan W; Berbée JF; Havekes LM; Rensen PC
J Lipid Res; 2006 Jun; 47(6):1203-11. PubMed ID: 16537968
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.
Bijland S; Pieterman EJ; Maas AC; van der Hoorn JW; van Erk MJ; van Klinken JB; Havekes LM; van Dijk KW; Princen HM; Rensen PC
J Biol Chem; 2010 Aug; 285(33):25168-75. PubMed ID: 20501652
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein lipase activity does not predict very low-density lipoprotein-triglyceride fatty acid oxidation during exercise.
Søndergaard E; Andersen IR; Sørensen LP; Gormsen LC; Nielsen S
Scand J Med Sci Sports; 2017 May; 27(5):474-481. PubMed ID: 28207959
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific postprandial clearance is the major determinant of PPARgamma-induced triglyceride lowering in the rat.
Laplante M; Festuccia WT; Soucy G; Blanchard PG; Renaud A; Berger JP; Olivecrona G; Deshaies Y
Am J Physiol Regul Integr Comp Physiol; 2009 Jan; 296(1):R57-66. PubMed ID: 18971352
[TBL] [Abstract][Full Text] [Related]
9. Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding.
Dorfmeister B; Zeng WW; Dichlberger A; Nilsson SK; Schaap FG; Hubacek JA; Merkel M; Cooper JA; Lookene A; Putt W; Whittall R; Lee PJ; Lins L; Delsaux N; Nierman M; Kuivenhoven JA; Kastelein JJ; Vrablik M; Olivecrona G; Schneider WJ; Heeren J; Humphries SE; Talmud PJ
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1866-71. PubMed ID: 18635818
[TBL] [Abstract][Full Text] [Related]
10. Dietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5-dependent and -independent mechanisms.
Treviño-Villarreal JH; Reynolds JS; Bartelt A; Langston PK; MacArthur MR; Arduini A; Tosti V; Veronese N; Bertozzi B; Brace LE; Mejia P; Trocha K; Kajitani GS; Longchamp A; Harputlugil E; Gathungu R; Bird SS; Bullock AD; Figenshau RS; Andriole GL; Thompson A; Heeren J; Ozaki CK; Kristal BS; Fontana L; Mitchell JR
JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385734
[TBL] [Abstract][Full Text] [Related]
11. The Hyplip2 locus causes hypertriglyceridemia by decreased clearance of triglycerides.
Moen CJ; Tholens AP; Voshol PJ; de Haan W; Havekes LM; Gargalovic P; Lusis AJ; van Dyk KW; Frants RR; Hofker MH; Rensen PC
J Lipid Res; 2007 Oct; 48(10):2182-92. PubMed ID: 17609525
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
Zsigmond E; Kobayashi K; Tzung KW; Li L; Fuke Y; Chan L
Hum Gene Ther; 1997 Nov; 8(16):1921-33. PubMed ID: 9382958
[TBL] [Abstract][Full Text] [Related]
13. ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression.
Gerritsen G; Rensen PC; Kypreos KE; Zannis VI; Havekes LM; Willems van Dijk K
J Lipid Res; 2005 Jul; 46(7):1466-73. PubMed ID: 15863838
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
[TBL] [Abstract][Full Text] [Related]
15. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ; Breckenridge WC
Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
17. Purified chickpea or lentil proteins impair VLDL metabolism and lipoprotein lipase activity in epididymal fat, but not in muscle, compared to casein, in growing rats.
Boualga A; Prost J; Taleb-Senouci D; Krouf D; Kharoubi O; Lamri-Senhadji M; Belleville J; Bouchenak M
Eur J Nutr; 2009 Apr; 48(3):162-9. PubMed ID: 19165521
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice.
Jong MC; Rensen PC; Dahlmans VE; van der Boom H; van Berkel TJ; Havekes LM
J Lipid Res; 2001 Oct; 42(10):1578-85. PubMed ID: 11590213
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5.
Fruchart-Najib J; Baugé E; Niculescu LS; Pham T; Thomas B; Rommens C; Majd Z; Brewer B; Pennacchio LA; Fruchart JC
Biochem Biophys Res Commun; 2004 Jun; 319(2):397-404. PubMed ID: 15178420
[TBL] [Abstract][Full Text] [Related]
20. Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway.
Karpe F; Hultin M
J Lipid Res; 1995 Jul; 36(7):1557-66. PubMed ID: 7595079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
